The development of irreversible ITK inhibitors as a potential new treatment for severe asthma

Sébastien André Campos, William Kerr, John D Harling, Angela M Deakin, Nick Barton, Dom Somers, Laiq Chaudry, Rachel Grimley, John William Barrett, Rebecca H Graves, Roberto Solari

Research output: Contribution to conferenceSpeech

Original languageEnglish
Publication statusPublished - 24 Apr 2014
Event25th Symposium on Medicinal Chemistry in Eastern England - Fielder Centre, Hatfield, Hatfield, United Kingdom
Duration: 24 Apr 201424 Apr 2014

Conference

Conference25th Symposium on Medicinal Chemistry in Eastern England
CountryUnited Kingdom
CityHatfield
Period24/04/1424/04/14

Keywords

  • ITK inhibitors
  • asthma treatment

Cite this

Campos, S. A., Kerr, W., Harling, J. D., Deakin, A. M., Barton, N., Somers, D., ... Solari, R. (2014). The development of irreversible ITK inhibitors as a potential new treatment for severe asthma. 25th Symposium on Medicinal Chemistry in Eastern England , Hatfield, United Kingdom.